Xeriant Stock Performance
| XERI Stock | USD 0.01 0.0005 4.17% |
Xeriant holds a performance score of 8 on a scale of zero to a hundred. The firm maintains a market beta of -2.41, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Xeriant are expected to decrease by larger amounts. On the other hand, during market turmoil, Xeriant is expected to outperform it. Use Xeriant downside variance, as well as the relationship between the accumulation distribution and price action indicator , to analyze future returns on Xeriant.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Xeriant are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, Xeriant demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 962.5 K | |
| Total Cashflows From Investing Activities | -135.3 K |
Xeriant |
Xeriant Relative Risk vs. Return Landscape
If you would invest 0.80 in Xeriant on September 26, 2025 and sell it today you would earn a total of 0.45 from holding Xeriant or generate 56.25% return on investment over 90 days. Xeriant is currently generating 1.4451% in daily expected returns and assumes 12.8058% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Xeriant, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Xeriant Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xeriant's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Xeriant, and traders can use it to determine the average amount a Xeriant's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1129
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | XERI | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Xeriant is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xeriant by adding it to a well-diversified portfolio.
Xeriant Fundamentals Growth
Xeriant OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Xeriant, and Xeriant fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xeriant OTC Stock performance.
| Return On Equity | -36.34 | |||
| Return On Asset | -7.56 | |||
| Current Valuation | 14.9 M | |||
| Shares Outstanding | 376.93 M | |||
| Price To Book | 4.26 X | |||
| Price To Sales | 27.51 X | |||
| EBITDA | (11.1 M) | |||
| Cash And Equivalents | 1.14 M | |||
| Total Debt | 4.08 M | |||
| Debt To Equity | 0.66 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (6.93 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 1.27 M | |||
About Xeriant Performance
By evaluating Xeriant's fundamental ratios, stakeholders can gain valuable insights into Xeriant's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Xeriant has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Xeriant has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Xeriant, Inc. operates as an aerospace technology and advanced materials holding company in the United States. Xeriant, Inc. was incorporated in 2009 and is headquartered in Boca Raton, Florida. Xeriant operates under Aerospace Defense classification in the United States and is traded on OTC Exchange.Things to note about Xeriant performance evaluation
Checking the ongoing alerts about Xeriant for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Xeriant help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Xeriant is way too risky over 90 days horizon | |
| Xeriant has some characteristics of a very speculative penny stock | |
| Xeriant appears to be risky and price may revert if volatility continues | |
| Xeriant has high likelihood to experience some financial distress in the next 2 years | |
| Xeriant currently holds 4.08 M in liabilities with Debt to Equity (D/E) ratio of 0.66, which is about average as compared to similar companies. Xeriant has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Xeriant until it has trouble settling it off, either with new capital or with free cash flow. So, Xeriant's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Xeriant sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Xeriant to invest in growth at high rates of return. When we think about Xeriant's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (13.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Xeriant currently holds about 1.14 M in cash with (6.93 M) of positive cash flow from operations. |
- Analyzing Xeriant's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xeriant's stock is overvalued or undervalued compared to its peers.
- Examining Xeriant's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Xeriant's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xeriant's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Xeriant's otc stock. These opinions can provide insight into Xeriant's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Xeriant OTC Stock analysis
When running Xeriant's price analysis, check to measure Xeriant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeriant is operating at the current time. Most of Xeriant's value examination focuses on studying past and present price action to predict the probability of Xeriant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeriant's price. Additionally, you may evaluate how the addition of Xeriant to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |